Scientific support services to understand how shelf life and stability over the expiry of drugs affects the safety and efficacy of drugs. Develop screening and testing methods of complex drugs with…
Ended Awarded Last action
- Contract number
- 75F40121F19059
- Awardee
-
Midnight Sun Technologies LLC UEI ZKR5F6EZNAD2 Part of Kikiktagruk Inupiat Corp
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $151,141
Award facts
- Contract value 100% obligated
- $151,141.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Time and Materials
- Place of performance
- St. Louis, MO 63110, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$8,209 | |
| Other Administrative Action | $0 | |
| Original award | $159,350 |
About this award
The U.S. Food and Drug Administration awarded Midnight Sun Technologies LLC a $151,141 one-year delivery order to provide scientific support services to improve understanding of how shelf life and stability over the expiry period of drugs affects safety and efficacy, with a focus on developing screening and testing methods for complex drugs' extractables and leachables. Midnight Sun Technologies, a Virginia-based division of Kikiktagruk Inupiat Corp, will perform the work in St. Louis, Missouri on a time and materials basis to assist the FDA in ensuring drug quality and reducing health risks to patients from expired or unstable medications. No subcontractors or set aside designations were identified.
Description
Scientific support services to understand how shelf life and stability over the expiry of drugs affects the safety and efficacy of drugs. Develop screening and testing methods of complex drugs with a special emphasis on extractables and leachables TH
Quick answers
Who was awarded contract 75F40121F19059?
75F40121F19059 was awarded to Midnight Sun Technologies LLC by Food and Drug Administration (Department of Health and Human Services) on May 26, 2021.
How much is contract 75F40121F19059 worth?
The government has obligated $151,141 on 75F40121F19059.
Is contract 75F40121F19059 an order under another contract?
Yes. 75F40121F19059 is a delivery order under 75F40119D10015, an indefinite delivery contract.
Was contract 75F40121F19059 competed?
The extent of competition for 75F40121F19059 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award